SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-318564
Filing Date
2021-11-03
Accepted
2021-11-03 17:00:44
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d236973ds3.htm S-3 344518
2 EX-4.6 d236973dex46.htm EX-4.6 307886
3 EX-4.8 d236973dex48.htm EX-4.8 96956
4 EX-4.9 d236973dex49.htm EX-4.9 97764
5 EX-4.10 d236973dex410.htm EX-4.10 87722
6 EX-5.1 d236973dex51.htm EX-5.1 26258
7 EX-23.1 d236973dex231.htm EX-23.1 1666
8 GRAPHIC g236973g01a10.jpg GRAPHIC 42046
9 GRAPHIC g236973g1102225022606.jpg GRAPHIC 2406
  Complete submission text file 0001193125-21-318564.txt   1019536
Mailing Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142
Business Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142 617-425-9200
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-260718 | Film No.: 211376335
SIC: 2834 Pharmaceutical Preparations